Bristol-Myers Squibb Company
Stock Details
Is it expensive?
Trailing P/E Ratio
16.71
Forward P/E Ratio
9.42
PEG Ratio
0.01
8.23
Price-to-Sales (TTM)
2.45
6.37
9.07
Market Cap
117.75B
157.37B
Is it profitable?
Net Profit Margin (TTM)
14.64%
Gross Profit Margin
67.23%
Diluted EPS (TTM)
3.46
40.44%
48.19B
Is it growing?
1.30%
1,409.70%
Is it risky?
0.27
254.98
1.26
47.19B
Who owns it?
83.15%
0.09%
1.46%
2.04B
2.03B
Does it pay?
4.37%
71.97%
Apr 2, 2026
May 1, 2026
How much cash?
10.67B
14.16B
11.15B
5.24
- Price
- 59.19
- Percent Change
- +1.52 (2.64%)
- Previous Close
- 57.67
- Open
- 57.92
- Low
- 57.68
- High
- 59.20
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$59.19
From 52W Low
+39.21%
From 52W High
-5.88%
Today
+2.64%
1Y Change
+10.14%
6M
$44.68
3M
$55.86
1M
$60.63
Today
$59.19
From 52W Low
+39.21%
From 52W High
-5.88%
Today
+2.64%
1Y Change
+10.14%
6M
$44.68
3M
$55.86
1M
$60.63
Today
$59.19
Expensive
within its 1-year price range
$59.19
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-2.4%
3M
+6.0%
6M
+32.5%
1Y
+10.1%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bristol-Myers Squibb Company
- Founded
- Aug 5, 1933
- Founders
- William McLaren Bristol, John Ripley Myers, Edward Robinson Squibb
- CEO
- Christopher S. Boerner
- Employees
- 32,500
- Fiscal Year End
- Dec 31, 2025
- Address
430 East 29th Street, 14th Floor
New York
New York
10016
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.bms.com
Indicators
Operating Cash Flow
14.16B
Net Income
7.05B
Real Earnings
2.01
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
14.16B
Net Income
7.05B
Real Earnings
2.01
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
16.71
Forward P/E Ratio
9.42
PEG Ratio
0.01
8.23
Price-to-Sales (TTM)
2.45
6.37
9.07
Market Cap
117.75B
157.37B
Is it profitable?
Net Profit Margin (TTM)
14.64%
Gross Profit Margin
67.23%
Diluted EPS (TTM)
3.46
40.44%
48.19B
Is it growing?
1.30%
1,409.70%
Is it risky?
0.27
254.98
1.26
47.19B
Who owns it?
83.15%
0.09%
1.46%
2.04B
2.03B
Does it pay?
4.37%
71.97%
Apr 2, 2026
May 1, 2026
How much cash?
10.67B
14.16B
11.15B
5.24
- Price
- 59.19
- Percent Change
- +1.52 (2.64%)
- Previous Close
- 57.67
- Open
- 57.92
- Low
- 57.68
- High
- 59.20
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$59.19
From 52W Low
+39.21%
From 52W High
-5.88%
Today
+2.64%
1Y Change
+10.14%
6M
$44.68
3M
$55.86
1M
$60.63
Today
$59.19
From 52W Low
+39.21%
From 52W High
-5.88%
Today
+2.64%
1Y Change
+10.14%
6M
$44.68
3M
$55.86
1M
$60.63
Today
$59.19
Expensive
within its 1-year price range
$59.19
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-2.4%
3M
+6.0%
6M
+32.5%
1Y
+10.1%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bristol-Myers Squibb Company
- Founded
- Aug 5, 1933
- Founders
- William McLaren Bristol, John Ripley Myers, Edward Robinson Squibb
- CEO
- Christopher S. Boerner
- Employees
- 32,500
- Fiscal Year End
- Dec 31, 2025
- Address
430 East 29th Street, 14th Floor
New York
New York
10016
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.bms.com